Tonix Pharmaceuticals Holding Corp. Watch

from 8-K 43 pages Tonix Pharmaceuticals Holding Corp. Common Stock Sales Agreement

from 8-K 25 pages This Letter (This “Agreement”) Constitutes the Agreement Between Tonix Pharmaceuticals Holding Corp., a Nevada Corporation (The “Company”) and Dawson James Securities, Inc. (“Dawson”) Pursuant to Which Dawson Shall Serve as the Placement Agent (The “Placement Agent”) (The “Services”), for the Company, on a Reasonable “Best Efforts” Basis, in Connection With the Proposed Offer and Placement (The “Offering”) by the Company of Its Securities (As Defined Section 3 of This Agreement). the Company Expressly Acknowledges and Agrees That Dawson’s Obligations Hereunder Are on a Reasonable “Best Efforts” Basis Only and That the Execution of This Agreement Does Not Constitute a Commitment by Dawson to Purchase the Securities and Does Not Ensure the Successful Placement of the Securities or Any Portion Thereof or the Success of Dawson Placing the Securities. the Terms of the Placement and the Securities Shall Be Mutually Agreed Upon by the Company and the Purchasers and Nothing Herein Constitutes That the Placement Agent Would Have the Power or Authority to Bind the Company or Any Purchaser or an Obligation for the Company to Issue Any Securities or Complete the Offering. This Agreement and the Documents, if Any, Executed and Delivered by the Company and the Purchasers in Connection With the Offering, Including but Not Limited to the Purchase Agreement (As Defined Below) Shall Be Collectively Referred to Herein as the “Transaction Documents.” Appointment of Dawson James Securities, Inc. as Exclusive Placement Agent

from 8-K 25 pages Placement Agency Agreement

from 8-K 22 pages Placement Agency Agreement

from 8-K 9 pages March 28, 2024 Tonix Pharmaceuticals Holding Corp. Attention: Seth Lederman 26 Main Street, Suite 101 Chatham, New Jersey 07928 Re: Placement Agency Agreement Dear Mr. Lederman

from 8-K 9 pages December 20, 2023 Tonix Pharmaceuticals Holding Corp. Attention: Seth Lederman 26 Main Street, Suite 101 Chatham, New Jersey 07928 Re: Placement Agency Agreement Dear Mr. Lederman

from 8-K 10 pages September 28, 2023 Tonix Pharmaceuticals Holding Corp. Attention: Seth Lederman 26 Main Street, Suite 101 Chatham, New Jersey 07928 Re: Placement Agency Agreement Dear Mr. Lederman

from 8-K 8 pages July 27, 2023 Tonix Pharmaceuticals Holding Corp. Attention: Seth Lederman 26 Main Street, Suite 101 Chatham, New Jersey 07928 Re: Placement Agency Agreement Dear Mr. Lederman

from 8-K 81 pages Asset Purchase Agreement by and Among Upsher-Smith Laboratories, LLC, as Seller, Tonix Medicines, Inc. as Purchaser, and Tonix Pharmaceuticals Holding Corp., as Parent Dated as of June 23, 2023

from SC 13G/A ~1 page Exhibit 1 Joint Acquisition Statement Pursuant to Section 240.13d-1

from S-3 42 pages Tonix Pharmaceuticals Holding Corp. Common Stock Sales Agreement

from S-1/A 49 pages Underwriting Agreement Between Tonix Pharmaceuticals Holding Corp. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from S-1/A 47 pages Underwriting Agreement Between Tonix Pharmaceuticals Holding Corp. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from 10-Q 31 pages Exhibit 1.01

from S-1/A 35 pages Shares of Common Stock of Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from S-1/A 35 pages Shares of Common Stock of Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from SC 13G 1 page Joint Filing Agreement Pursuant to Rule 13d-1

from 8-K 49 pages Underwriting Agreement Between Tonix Pharmaceuticals Holding Corp. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters 1 Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from S-1/A 49 pages Underwriting Agreement Between Tonix Pharmaceuticals Holding Corp. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters 1 Tonix Pharmaceuticals Holding Corp. Underwriting Agreement

from S-3 32 pages Tonix Pharmaceuticals Holding Corp. $9,500,000 Common Stock Sales Agreement